Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 707 of 1,261
  1. US 9272034

    Treatment of conditions related to shock

    The Regents of the University of California · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  2. US 9272027

    Francisella tularensis live vaccine strains and methods of use

    United States of America as represented by the Secretary of the Air Force · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  3. US 9272023

    Use of ixolaris, a tissue factor inhibitor, for inhibiting angiogenesis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  4. US 2016051546

    CRYSTALLIZATION PROCESS OF ARIPIPRAZOLE DERIVATIVES IN EXTENDED RELEASE FORMULATIONS FOR TREATMENT OF SCHIZOPHRENIA

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Feb 25, 2016 · Expires Feb 20, 2036

    granted
  5. US 9265844

    Protease degradable polypeptides and uses thereof

    The Board of Regents of the University of Texas System · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted
  6. US 9265742

    Compositions and methods for treating inflammatory pain

    Infirst Healthcare Limited · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted
  7. US 9266834

    1, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors

    Addex Pharma, S.A. · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted
  8. US 9266873

    Pyridine derivatives

    Asana BioSciences, LLC · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted
  9. US 9265804

    Compositions and methods for treatment of cancer using bacteria

    Decoy Biosystems, Inc. · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted
  10. US 9266960

    Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted
  11. US 9267947

    Compositions and methods for preventing or treating Burkholderia infection

    The Board of Regents of the University of Texas System · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted
  12. US 9267151

    STXBP1 overexpressing mouse and its uses in screening of treatments for neuropsychiatric illness

    UNIVERSIDAD DEL PAÍS VASCO / EUSKAL HERRIKO UNIBERTSITATEA · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted
  13. US 9266845

    Oligomer-containing substituted aromatic triazine compounds

    Nektar Therapeutics · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted
  14. US 9267154

    Targeted integration into the PPP1R12C locus

    Sangamo Biosciences, Inc. · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted
  15. US 9267139

    Compositions and methods for treating musculoskeletal diseases and disorders

    Georgia Regents Research Institute, Inc. · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted
  16. US 9267123

    Methods and compositions for gene correction

    Sangamo Biosciences, Inc. · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted
  17. US 9266933

    Polypeptides inhibiting neovascularization and uses thereof

    SHANGHAI FIRST PEOPLE'S HOSPITAL · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted
  18. US 9267112

    Adenovirus isolated from Titi Monkeys

    The Regents of the University of California · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted
  19. US 9266931

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted
  20. US 9266928

    Deletion of the beta 20-21 loop in HIV GP120 exposes the CD4 binding site for improved antibody binding and antibody induction

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted
  21. US 9266874

    Heterocycle amines and uses thereof

    Ligand Pharmaceuticals Incorporated · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted
  22. US 9266861

    Method of synthesizing thyroid hormone analogs and polymorphs thereof

    Madrigal Pharmaceuticals, Inc. · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted
  23. US 9266901

    Compositions and methods for treating cancer

    The Regents of the University of California · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted
  24. US 9266912

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.